The present invention relates to new enamine derivatives of daunorubicin and adriamycin of the formula l: ##STR1## and formula 2: ##STR2## wherein R denotes a hydrogen atom or hydroxyl group. The inventive compounds are useful antineoplastic antibiotics utilized in the treatment of cancer, primarily leukemia. The present derivatives demonstrate a reduction in toxicity, in particular cardiotoxicity, over their parent compounds, while retaining chemotherapeutic properties.
本发明涉及新的达诺霉素和
阿霉素的恩胺衍
生物,其
化学式为1:##STR1##和
化学式2:##STR2##其中R表示氢原子或羟基。本发明的化合物是有用的抗肿瘤抗生素,主要用于白血病的治疗。与其母体化合物相比,本衍
生物表现出毒性降低,尤其是心脏毒性降低,同时保留了化疗性能。